Search | IOVS | ARVO Journals

View

Showing 1 – 16 of 16

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2013

Reduced expression of IL17 following rejection in baby rat keratoplasty

Antonia Hildebrand; Thomas Reinhard; Johannes Schwartzkopff; Cornea - Immunology

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2066. doi:

ARVO Annual Meeting Abstract March 2012

Strong Anti-inflammatory Effect Of Topical Ayzthromycin Following Corneal Transplantation

Johannes Schwartzkopff; Katrin Wacker; Yvonne Kern; Laura Bredow; Antonia Hildebrand; Thomas Reinhard

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2372. doi:

ARVO Annual Meeting Abstract March 2012

Survival Of Different Corneal Cell Layers Following Experimental Limbo-keratoplasty

Laura Bredow; Katrin Wacker; Thomas Reinhard; Johannes Schwartzkopff

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3518. doi:

ARVO Annual Meeting Abstract March 2012

Reduced Corneal Inflammation By Birch Leave Extract In Combination With Sub-therapeutic Cyclosporin A

Katrin Wacker; Carsten Gründemann; Roman Huber; Thomas Reinhard; Johannes Schwartzkopff

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6176. doi:

ARVO Annual Meeting Abstract April 2011

Subconjunctival Transfer of Regulatory T Cells Promotes Corneal Graft Survival

Christian Jarsch; Laura Bredow; Yvonne Kern; Daniel Böhringer; Philipp Eberwein; Thomas Reinhard; Johannes Schwartzkopff

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1147. doi:

ARVO Annual Meeting Abstract April 2011

Sanglifehrin A Promotes Allograft Survival in Rat Keratoplasty

Johannes Schwartzkopff; Leslie Y. Olivares Valdez; Laura Bredow; Armin Buchwald; Daniel Böhringer; Thomas Reinhard

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1159. doi:

ARVO Annual Meeting Abstract April 2011

Influence Of Early Amniotic Membrane And Mesenchymal Stem Cell Transplantation On The Clinical Outcome After Severe Corneal Burn In Rats

Andreas Heidt; Philipp Eberwein; Daniel Böhringer; Johannes Schwartzkopff; Yvonne Kern; Thomas Reinhard

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1992. doi:

ARVO Annual Meeting Abstract April 2010

Evaluation of a New Fibrin Based Drug Delivery System to Prevent Allograft Rejection in Rat Keratoplasty

J. Schwartzkopff; A. J. Hyatt; L. Bredow; C. Noack; P. Eberwein; K. R. Martin; T. Reinhard

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):1616. doi:

ARVO Annual Meeting Abstract April 2010

Host Endothelium on Formerly Rejected Corneal Grafts in the Rat

L. Bredow; S. Mahlenbrey; D. Boehringer; T. Reinhard; J. Schwartzkopff

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2837. doi:

ARVO Annual Meeting Abstract April 2009

Corneal Antigen Presenting Cells Promote Allograft Survival

J. Schwartzkopff; D. R. Saban; A. Beiter; I. T. Gross; F. Birnbaum; D. Böhringer; T. Reinhard

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1964. doi:

ARVO Annual Meeting Abstract April 2009

Nk-Depletion Deletes Rejection in a Baby Rat Keratoplasty Model

L. Bredow; J. Schwartzkopff; S. L. Schlereth; C. Jarsch; F. Birnbaum; D. Boehringer; T. Reinhard

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1970. doi:

ARVO Annual Meeting Abstract April 2009

Effect of Bevacizumab on the Immune Privileged Status of Retinal Pigment Epithelial Cells

E. Blaeser; J. Schwartzkopff; Y. Kern; D. Böhringer; H. Agostini; T. Reinhard

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1180. doi:

ARVO Annual Meeting Abstract May 2007

Accelerated Corneal Allograft Rejection in Young versus Mature Rats

J. Schwartzkopff; M. Berger; I. Gross; P. Eberwein; F. Birnbaum; T. Reinhard

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):198. doi:

ARVO Annual Meeting Abstract May 2007

Donor-Derived Conjunctival Cells After Haematopoietic Stem Cell Transplantation

P. Eberwein; P. Faber; D. Boehringer; J. Schwartzkopff; A. Spyridonidis; T. Reinhard

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):464. doi:

ARVO Annual Meeting Abstract May 2006

Systemic FK778 Prolongs Clear Graft Survival in the Rat Keratoplasty Model

F. Birnbaum; J. Schwartzkopff; C. Scholz; A. Reis; T. Reinhard

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1283. doi:

ARVO Annual Meeting Abstract May 2004

CTLA–4+ CD8+ T cells that encounter B7.2+ iris pigment epithelial cells express their own B7.2 to achieve global suppression of T cell activation

J. Schwartzkopff; S. Sugita; T.F. Ng; J.W. Streilein

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):588. doi:

Advertisement